ValueScreener

ValueScreener company report

Warby Parker Inc. (WRBY)

NYSE / Healthcare / Medical - Instruments & Supplies

Share price

24.59 USD Market dataClose of Oct 15, 2026

Market capitalisation

3.04B USD Market dataClose of Oct 15, 2026
Market data
Oct 15, 2026
Filed accounts
FY2025, filed Feb 26, 2026
Ratios computed
Oct 15, 2026
Filed years
7, FY2019 to FY2025
Four kinds of sourceSEC filingCompany statementMarket dataComputedWhat each means
SEC filingFiled with the SEC
Read from a statement the company filed with the SEC, with the form, fiscal year, filing date and accession beside it.
Company statementCompany statement
What the company says about itself in a filing: an 8-K item, the auditor, its own segment names.
Market dataMarket data
Prices, market value and what analysts publish, with the date they are as of.
ComputedComputed by ValueScreener
Worked out by us from the other three, with the inputs and the formula one press away. A score is a research output, not a rating or a recommendation.
Reading

1 of 10

Overview

What the business is, what it costs, and how it reads on four questions.

Market dataSEC filingComputed

Four questions, at a glance

Quality

Return on invested capital, after tax

-0.9% Computed

From the FY2025 filing

Read quality

Valuation

Price to earnings

2459.00x Computed

FY2025 accounts, priced at the latest close

Read valuation

Cash generation

Free cash flow yield

1.4% Computed

FY2025 accounts, priced at the latest close

Read cash generation

Revenue and net income, as filed

FY2019 Revenue: 370.5M USDFY2019 Net income: 0.00 USDFY2020 Revenue: 393.7M USDFY2020 Net income: -55.9M USDFY2021 Revenue: 540.8M USDFY2021 Net income: -144.3M USDFY2022 Revenue: 598.1M USDFY2022 Net income: -110.4M USDFY2023 Revenue: 669.8M USDFY2023 Net income: -63.2M USDFY2024 Revenue: 771.3M USDFY2024 Net income: -20.4M USDFY2025 Revenue: 871.9M USDFY2025 Net income: 1.6M USD
Revenue Net income7 filed fiscal years, from the annual reports; the table in Filings names each document.
Named tests met
1 of 30 Which tests
The business, and the score behind its five axes

The reading, in brief

Is it cheap

Price to earnings is 2,459.00x at the close of 2026-10-15 on FY2025 figures; the lines are 15.00x (Graham's defensive ceiling) and, by market convention, 10.00x, 25.00x and 40.00x, and this sits above the highest.

Today, against the Healthcare sector (223 companies), 2,459.00x sits at the 100th percentile; the middle half of that group runs from 13.52x to 42.98x.

Is it good

Return on invested capital was -0.9% in FY2025, in the band labelled "Likely below the cost of capital" (below 8.0%), on lines anchored on Damodaran's cost-of-capital data, suggesting returns below the usual cost of the capital employed.

Today, against the Healthcare sector (233 companies), -0.9% sits at the 40th percentile; the middle half of that group runs from -37.4% to 12.8%.

Is it safe

Warby Parker Inc. held more cash than debt at the end of FY2025 (net cash of 53.2m USD), so net debt to EBITDA is a net cash position rather than a leverage reading.

Year by year against peers
Whether Warby Parker Inc.'s return on equity stayed above the median of the Medical - Instruments & Supplies industry, year by year. (FY2021 to FY2025, 5 fiscal years of Warby Parker Inc. with a comparable figure)
The direction
Which way Warby Parker Inc.'s gross margin has moved, and how steadily. (FY2019 to FY2025, 7 filed years of Warby Parker Inc.)
What could explain it
What in Warby Parker Inc.'s filed statements could explain the movements. (5 readings drawn from the statement lines Warby Parker Inc. filed)
What to check next
What to check next on Warby Parker Inc., and where in its filings. (4 questions for Warby Parker Inc.)
In one paragraph
One paragraph on Warby Parker Inc.'s returns, cash, balance sheet and price. (13 of sixteen figures read for Warby Parker Inc.)

These are WRBY’s filed figures. The research desk says what they mean, against peers and its own years, with what to check next.

Research WRBYPart of Serious. New accounts start with 30 days of Professional, free, no card.

2 of 10

What changed

The newest filing, what it moved, and when the next one is due.

SEC filingCompany statement

The newest accounts on file are the FY2025 annual report: 10-K, filed Feb 26, 2026, accession 0001504776-26-000006.

3 of 10

Quality

The returns the business earns on its capital, and the margins behind them.

SEC filingComputed

Warby Parker Inc: returns on capital and margins, each with its source
FigureValue, source and document
Return on invested capital, after tax-0.9% ComputedFY2025 10-K, filed Feb 26, 2026, 0001504776-26-000006
Return on equity0.5% ComputedFY2025 10-K, filed Feb 26, 2026, 0001504776-26-000006
Return on capital employed, pre-tax-0.9% ComputedFY2025 10-K, filed Feb 26, 2026, 0001504776-26-000006
Return on assets0.2% ComputedFY2025 10-K, filed Feb 26, 2026, 0001504776-26-000006
Gross margin54.0% ComputedFY2025 10-K, filed Feb 26, 2026, 0001504776-26-000006
Operating margin-0.6% ComputedFY2025 10-K, filed Feb 26, 2026, 0001504776-26-000006
Net margin0.2% ComputedFY2025 10-K, filed Feb 26, 2026, 0001504776-26-000006
WRBY 0.2%
ICUI 0.0%ATRC -2.1%STVN 11.8%MMSI 8.5%TFX -45.5%
-45.5%11.8%
Net margin: WRBY against the 5 companies named under Valuation context, each as filed for its own latest year. Placement only: no average is drawn.

4 of 10

Financial strength

What it owes against what it owns, and whether it can meet what falls due.

SEC filingComputedCompany statement

Warby Parker Inc: leverage, liquidity and distress, each with its source
FigureValue, source and document
Debt to equity0.63 ComputedFY2025 10-K, filed Feb 26, 2026, 0001504776-26-000006
Current ratio2.35 ComputedFY2025 10-K, filed Feb 26, 2026, 0001504776-26-000006
Quick ratio2.05 ComputedFY2025 10-K, filed Feb 26, 2026, 0001504776-26-000006
Interest coverage
Why n/a

No interest expense is filed for this year, so coverage is not computed.

n/a ComputedFY2025 10-K, filed Feb 26, 2026, 0001504776-26-000006
Altman Z-score5.42 ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 26, 2026, 0001504776-26-000006
Net debt-53.2M ComputedFY2025 10-K, filed Feb 26, 2026, 0001504776-26-000006
Total assets 720.9MTotal liabilities 353.2MShareholders' equity 367.7MOwnsOwes, and equity
Total assets Total liabilities Shareholders’ equity
The balance sheet, line by line

Financial health

What Warby Parker Inc owned and owed at the end of fiscal 2025, from the balance sheet it filed (10-K, filed Feb 26, 2026, 0001504776-26-000006).

Warby Parker Inc: balance sheet position
Total assets720.9M FiledFY2025 10-K, filed Feb 26, 2026
Total liabilities353.2M FiledFY2025 10-K, filed Feb 26, 2026
Shareholders' equity367.7M FiledFY2025 10-K, filed Feb 26, 2026
Cash286.4M FiledFY2025 10-K, filed Feb 26, 2026
Total debt233.1M FiledFY2025 10-K, filed Feb 26, 2026
Net debt-53.2M
Current ratio2.35
Debt to equity0.63
  • Interest cover: FY2025: No interest expense is filed for this year, so coverage is not computed.

Read from the filed balance sheet for each year, with the income statement of the same year supplying operating profit where a ratio needs it. Nothing here is a view on whether this company is sound.

5 of 10

Valuation context

What the market charges for it, against its own record and companies like it.

Market dataSEC filingComputed

Warby Parker Inc: what the market charges, each with its source
FigureValue, source and document
Price to earnings2459.00x ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 26, 2026, 0001504776-26-000006
P/E on trailing twelve months433.17x ComputedClose of Oct 15, 2026 · Trailing four quarters, each as known on the day; the quarterly filings are listed under Filings
Price to book8.37x ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 26, 2026, 0001504776-26-000006
Price to sales3.53x ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 26, 2026, 0001504776-26-000006
Enterprise value to EBIT
Why n/a

We do not hold this figure for this company, so there is nothing to show.

n/a ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 26, 2026, 0001504776-26-000006
Enterprise value to EBITDA67.26x ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 26, 2026, 0001504776-26-000006
Price to earnings over growth
Why n/a

We do not hold this figure for this company, so there is nothing to show.

n/a ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 26, 2026, 0001504776-26-000006
Diluted earnings per share0.01 USD FiledFY2025 10-K, filed Feb 26, 2026, 0001504776-26-000006
Graham number0.81 USD ComputedFY2025 10-K, filed Feb 26, 2026, 0001504776-26-000006

We publish no fair value or price target of our own. Value WRBY on your own assumptions in the DCF workbench, starting from the filed figures.

Its own record, and companies like it

Valuation

What the market charges for Warby Parker Inc today, and the multiples it has carried. No value of ours: the figures are the filings’ and the market’s.

Warby Parker Inc: valuation
Share price24.59 USD
Market capitalisation3.04B USD
Enterprise value to EBITDA67.26x
Graham number0.81 USD
Diluted earnings per share, FY20250.01 USD

Price to earnings on trailing twelve months, a different basis from the fiscal-year P/E above, since Aug 11, 2022: low 375.00x, median 2359.00x, high 3034.00x, latest 433.17x. 233 trading days with a meaningful ratio, 813 more on a loss and left out. Each close over the trailing twelve months of earnings as known that day: a quarter counts from the day it was filed.

Companies like Warby Parker Inc

  1. ICU Medical, Inc. (ICUI)Market cap 4.18B USD
  2. AtriCure, Inc. (ATRC)Market cap 2.94B USD
  3. Stevanato Group S.p.A. (STVN)Market cap 5.25B USD
  4. Merit Medical Systems, Inc. (MMSI)Market cap 5.35B USD
  5. Teleflex Incorporated (TFX)Market cap 5.43B USD

Same industry (Medical - Instruments & Supplies) and size band (Mid, 2B to 10B), nearest in market value, net margin and current ratio. Each of those counts equally, by how many of the companies considered sit between the two on it. Closest first: the order is likeness and nothing else.

6 of 10

Cash generation

Whether profit arrives as cash, and what is paid back to shareholders.

SEC filingComputed

Warby Parker Inc: cash generation and what is paid out, each with its source
FigureValue, source and document
Free cash flow yield1.4% ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 26, 2026, 0001504776-26-000006
Free cash flow43.7M USD ComputedFY2025 10-K, filed Feb 26, 2026, 0001504776-26-000006
Free cash flow margin5.0% ComputedFY2025 10-K, filed Feb 26, 2026, 0001504776-26-000006
Dividend yield
Why n/a

We do not hold this figure for this company, so there is nothing to show.

n/a ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 26, 2026, 0001504776-26-000006
Payout ratio
Why n/a

We do not hold this figure for this company, so there is nothing to show.

n/a ComputedFY2025 10-K, filed Feb 26, 2026, 0001504776-26-000006
FY2019 Free cash flow: -11.2M USDFY2019 Net income: 0.00 USDFY2020 Free cash flow: 12.7M USDFY2020 Net income: -55.9M USDFY2021 Free cash flow: -80.5M USDFY2021 Net income: -144.3M USDFY2022 Free cash flow: -49.8M USDFY2022 Net income: -110.4M USDFY2023 Free cash flow: 7.3M USDFY2023 Net income: -63.2M USDFY2024 Free cash flow: 34.7M USDFY2024 Net income: -20.4M USDFY2025 Free cash flow: 43.7M USDFY2025 Net income: 1.6M USD
Free cash flow Net incomeProfit that arrives as cash stands level with net income; a gap year after year is worth reading about.

7 of 10

Filings

Every figure, the year it is for and the document it was read from.

SEC filingMarket data

The filed figures

Computed from the accounts this company filed with the SEC and, in a ratio with a price in it, the last close, dated on this page. Every filed figure below carries the fiscal year and the filing date its accounts were read from, and every blank carries the reason it is blank. Nothing here is a view on this company.

Warby Parker Inc.: the eight ratios, with the fiscal year and filing date behind each.
FigureValueYearAs of
2459.00xFY2025Oct 15, 2026
8.37xFY2025Oct 15, 2026
n/aFY2025Oct 15, 2026
n/a Operating profit is zero or negative, so there is no profit for a buyer's price to be a multiple of.
1.4%FY2025Oct 15, 2026
-0.9%FY2025Feb 26, 2026
n/aFY2025Oct 15, 2026
n/a The filed cash flow statement reports no dividend paid at all. That is not the same as a filed zero, and we will not read it as one.
0.63FY2025Feb 26, 2026
2.35FY2025Feb 26, 2026
3.53xFY2025Oct 15, 2026
n/aFY2025Oct 15, 2026
n/a This figure compares a year against the one before it, and we hold one filed year for this company.
5.42FY2025Oct 15, 2026
-2.43FY2025Feb 26, 2026
5/9FY2025Feb 26, 2026

The figures are computed from the accounts for fiscal 2025, the newest full year on file. 7 filed fiscal years on record, FY2019 to FY2025, from SEC EDGAR. Prices as of Oct 15, 2026. Ratios recomputed Oct 15, 2026. Two facts, because a recompute is not a fresh quote.

The year and the filing date name the statement each figure’s accounts are read from, and they stand even where the figure itself could not be computed: the line beneath a blank says what that statement did not carry. A figure’s name opens its formula and the filings behind it; a statement that names no SEC filing has no filing date, and reads n/a.

Ten years of filed figures, year by year

Ten years of filed figures

7 filed fiscal years, FY2019 to FY2025, read from the annual reports Warby Parker Inc filed with the SEC. Each year names its filing. Amounts in USD, as filed.

Warby Parker Inc: revenue, earnings, free cash flow and returns, by fiscal year, with the filing each year was read from
YearRevenueOperating incomeNet incomeEPS, dilutedFree cash flowOperating marginReturn on equityFiling
FY2025871.9M-5.3M1.6M0.0143.7M-0.6%0.5%10-K, Feb 26, 20260001504776-26-000006
FY2024771.3M-30.1M-20.4M-0.1734.7M-3.9%-6.0%10-K, Feb 27, 20250001504776-25-000010
FY2023669.8M-72.0M-63.2M-0.547.3M-10.8%-20.9%10-K, Feb 29, 20240001504776-24-000006
FY2022598.1M-111.2M-110.4M-0.96-49.8M-18.6%-38.5%10-K, Feb 28, 20230001504776-23-000006
FY2021540.8M-143.7M-144.3M-2.21-80.5M-26.6%-50.4%10-K, Mar 18, 20220001504776-22-000007
FY2020393.7M-55.6M-55.9M-1.0512.7M-14.1%n/m10-K, Mar 18, 20220001504776-22-000007
FY2019370.5M-1.7M0.00-1.10-11.2M-0.5%n/a10-K, Mar 18, 20220001504776-22-000007
  • Revenue, compound annual growth FY2019 to FY2025: 15.3%
  • Earnings: Earnings was not positive in both 2019 and 2025, so a compound rate across the window is not defined. Both figures are in the table.
  • Earnings per share: Earnings per share was not positive in both 2019 and 2025, so a compound rate across the window is not defined. Both figures are in the table.
  • Free cash flow: Free cash flow was not positive in both 2019 and 2025, so a compound rate across the window is not defined. Both figures are in the table.

Every figure in this section is a line of a filed annual statement or a ratio of two of them. Nothing here is estimated or smoothed. Earnings per share filed before a share split are put on today's share count, and say so. Nothing here is a verdict on the company.

8 of 10

Risks and guardrails

The accounting screens, the published tests, and the lines you can set to be told.

ComputedCompany statement

Warby Parker Inc: accounting screens and published tests, each with its source
FigureValue, source and document
Beneish M-score-2.43 ComputedFY2025 10-K, filed Feb 26, 2026, 0001504776-26-000006
Piotroski F-score5/9 ComputedFY2025 10-K, filed Feb 26, 2026, 0001504776-26-000006
Named tests met1 of 30 Computed
Beta1.39 ComputedClose of Oct 15, 2026

The named tests

Of 30 tests value investors published: 1 met, 28 not met, 1 we could not complete. Counts, never a score: a single figure would have to decide that meeting one investor’s criteria and meeting another’s are worth the same.

Which tests, by name(all 30)
Meets
Gross margin, turnover (Robert Novy-Marx)
Does not
Defensive investor (Benjamin Graham); Deep value; Large cap, low P/E; Earnings yield and ROIC (Joel Greenblatt); High F-score, low P/B (Joseph Piotroski); Three forensic scores; Low PEG, low debt (Peter Lynch); High returns and growth; EV/EBITDA and coverage; High yield, low payout; Dividends and buybacks; Low beta, profitable; ROIC at or above WACC; Near the 52-week low; Z-score and coverage (Edward Altman); Two thirds of NCAV (Benjamin Graham); P/E times P/B (Benjamin Graham); High returns, low debt; Owner earnings yield; High return on tangibles; Low P/S, rising earnings (James O'Shaughnessy); Book or below, low debt (Walter Schloss); Tangible book or below; Cash-flow yield and ROIC; Clean books, high ROIC; Cheapest quarter on P/E (David Dreman); Cheapest quarter on P/B (David Dreman); Low P/E, growth, yield (John Neff)
Not measured
Cash-covered dividend. A test with a figure we could not read is incomplete, never met and never failed.
Figures we could not read(8)
  • EV/EBIT: We do not hold this figure for this company, so there is nothing to show.
  • PEG Ratio: We do not hold this figure for this company, so there is nothing to show.
  • Eps Growth 5Y: We do not hold this figure for this company, so there is nothing to show.
  • Interest Coverage: No interest expense is filed for this year, so coverage is not computed.
  • Dividend Yield: We do not hold this figure for this company, so there is nothing to show.
  • Payout Ratio: We do not hold this figure for this company, so there is nothing to show.
  • Dividend Coverage Ratio: We do not hold this figure for this company, so there is nothing to show.
  • Dividend Streak: We do not hold this figure for this company, so there is nothing to show.

9 of 10

Declared positions

Whether anybody here owns this company.

Positions declared by the founder: no holding in any company shown here, as of October 3, 2026.

10 of 10

Next step

What to do with what you have read.

A thesis is your reason for owning it, in your words, with the figures that must stay true. Checking those figures every night against the newest filed accounts, and telling you once when one breaks, is what the subscription adds.

More on this company

What this cannot tell you

  • 8 figures could not be read on this company, among them EV/EBIT, PEG Ratio, Eps Growth 5Y. Each blank in the table above names the rest, with its reason. 1 named test comes back incomplete because of them, which is neither met nor missed.
  • We hold 7 filed fiscal years rather than 10, so the run above is shorter than a full decade and is counted as what it is.

And the one that is true of all of it: This is what the numbers say today. It cannot tell you the day one of them stops being true. Nothing here can, because the reasons are not written down.

Running this once is arithmetic on public documents and you are welcome to it. Writing down why you own each company, in your own words and with the numbers that have to stay true for it to hold, and then having those numbers re-checked every night against the newest filed accounts, and against the latest close where a rule watches a price, is Professional, the plan a new account starts on for 30 days, one trial per person. It writes to you the day one breaks, and stays quiet when nothing does. The check runs every night at 23:30 UTC. A filing is picked up the night after it is published.

Monitor my portfolioHow this is computed

No card. 30 free days, and nothing is charged unless you choose a plan.

Analyze your own portfolio

ValueScreener · valuescreener.ai · Computed from accounts filed with the SEC by this company, read from EDGAR, and from dated closing prices. On this page a filed figure opens into its formula, its inputs and the statement, fiscal year and filing date it was read from, and a price into the day of its close. A figure that cannot show that trail says so.

A computation on accounts filed with the SEC, not a recommendation and not advice. Past filings do not indicate future results. Risk disclaimer.

Margin Notes

Once a week, what changed in the filings of US-listed companies, why it can matter to a thesis, and what deserves a closer review. Grounded in filings, not market noise.

Site map

Apps

  • Android app coming soon
  • iPhone app coming soon
ValueScreener

Discover companies, research each one to its filings, track what matters, and take your work into your own spreadsheet.

ValueScreener is a trading name of Oliva Real Estate Technologies LLC, a Delaware limited liability company. Legal notices: legal@valuescreener.ai. © 2026 Oliva Real Estate Technologies LLC. All rights reserved.

Risk disclaimer. This service is provided for research and education only. Nothing on it is investment advice, a recommendation, or an offer to buy or sell any security. Capital is at risk, and past performance does not indicate future results. Figures come from filed accounts and may be incomplete, delayed or later restated, so verify a number against the filing before you act on it.

With your permission, Google Analytics, Microsoft Clarity and HubSpot set cookies to measure how this site and the product are used, including recordings of sessions. Nothing is set unless you allow it. Privacy policy